Home - GBS/CIDP Foundation International

GBS/CIDP Awareness Bracelets

You can now show your support every day for GBS/CIDP Foundation International by wearing an awareness bracelet. The silicone bracelets are made with our two colors and GBS/CIDP Foundation is embossed permanently in the band. The cost is $2.00 each. Place your order by calling 610-667-0131.

Centers of Excellence

Expert diagnosis & management of inflammatory neuropathies is critical to our patients. This is what our medical advisory board members had in mind when setting up the new Centers of Excellence program. We now have 12 healthcare facilities providing exactly that. More >>

One in 100,000

GBS & CIDP patients share their stories.

GBS/CIDP Foundation International: Our Commitment

The Foundation began over 30 years ago as a support group for patients & families impacted by Guillain‐Barré syndrome, chronic inflammatory demyelinating polyneuropathy (CIDP) or any of the variants that exist. Since then, our commitment has been to provide support to those affected by these disorders so that every patient obtains an early diagnosis, proper treatment & the opportunity for a full recovery. More >>

Topics of Interest

Walk & Roll for GBS-CIDP - Greater Delaware Valley

Saturday, June 8, 2013 - Wilson Farm Park

The Walk and Roll for GBS-CIDP is the new signature walk fundraising campaign of the GBS-CIDP Foundation International. This national Walk is designed to support the thousands of families forced to face the challenges caused by CIDP, GBS and its variants. Register or sponsor a participant today.

CIDP: Diagnosis and Treatment

Richard J. Barohn, MD, Professor and Chair Department of Neurology at the University of Kansas Medical Center, and a member of the GBS/CIDP Foundation International Medical Advisory Board gave a presentation to the Harris County Neurological Society in November – "CIDP: Diagnosis and Treatment". Sit back and watch the video (an hour long) and hear from one of the leading experts on CIDP in the world. Share it with your neurologist.

The PATH Study – CIDP Treatment with Subcutaneous Immunoglobulin

CSL Behring is currently recruiting CIDP patients for a clinical trial. Click above link for full access to view article.